A major discovery in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer protector protein is frequently disabled in several kinds of malignancies, causing https://companyspage.com/story6973642/mini-antibodies-reactivate-the-p53-protein-the-new-pathway-for-tumor-treatment